NCT06014840

The UCAP 2 Pilot Study

Early Diagnosis and Treatment of Undiagnosed COPD or Asthma: The UCAP 2 Trial - Pilot Study

• Status: Withdrawn
• Phase: N/A
• Study type: Interventional
• Enrollment: 0 (actual)
• Sponsor: Ottawa Hospital Research Institute · Academic / Other
• Sex: All
• Age: 18 Years
• Healthy volunteers: Not accepted

Summary

Our research group has found that Canadians with undiagnosed asthma or chronic obstructive pulmonary disease (COPD) have increased respiratory symptoms and worse health-related quality of life. The investigators recently developed and validated an on-line questionnaire to accurately identify these symptomatic, undiagnosed individuals. The investigators will advertise in the community asking individuals to complete the on-line questionnaire at home, at their leisure, to determine if they are at risk of asthma or COPD. Those at risk will be invited to participate in our randomized, controlled clinical trial to determine if guidelines-based treatment of newly discovered undiagnosed asthma or COPD will improve their quality of life and clinical outcomes.

Conditions

• COPD
• Asthma

Interventions

Type	Name	Description
OTHER	Assessment and Treatment provided to participant by a respirologist using evidence-based guidelines for asthma or COPD	Assessment and Treatment provided to participant by a respirologist using evidence-based guidelines for asthma or COPD

Timeline

• Start date: 2023-09-01
• Primary completion: 2027-12-01
• Completion: 2028-12-01
• First posted: 2023-08-28
• Last updated: 2024-04-25

Locations

1 site across 1 country: Canada